By Christopher P. Cannon (Editor), Patrick T. O'Gara (Editor)
Read or Download Critical Pathways in Cardiology PDF
Similar cardiology books
This e-book, and its spouse, "Fish body structure, quantity 12, half A", seeks to supply an important synthesis of contemporary advances, normal innovations, and variety of fish species. It units out to supply huge assurance of the foremost facets of cardiovascular body structure and to behave as an enormous resource ebook for the sector.
This ebook is the definitive reference on of the main fascinating components of cardiovascular examine – myocardial regeneration and stem phone treatment – for the therapy of sickness. Edited by way of pioneers within the quarter, with contributions from each significant investigator world wide, it covers: The biology of stem cells The activities of stem cells from the bone marrow, the guts, and embryos at the basic restorative and service features of the guts and blood vessels How stem cells may perhaps give a contribution to myocardial restoration within the face of harm and getting older How adjuvant remedy with progress elements could improve stem mobilephone job in regeneration and service scientific functions and medical reviews This absolutely referenced ebook offers the present nation of data in either simple technological know-how and medical perform, and is a vital reference for scientists, scholars, and clinicians.
''This publication presents useful hands-on recommendation at the use of other equipment of high blood pressure therapy. It describes mechanisms of hypertension and high blood pressure, universal factors of high blood pressure, and conventional drugs used to regard the disorder and their uncomfortable side effects. The publication information substitute tools of treating high blood pressure, emphasizing their mechanisms of motion, similarities to straightforward medicinal drugs, and sensible implementation recommendation.
Additional info for Critical Pathways in Cardiology
Aspirin as a therapeutic agent in cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation 1997;96:2751–2753. 29. Hjalmarson A, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction, a double-blind randomized trial. Lancet 1981;2:823–827. 30. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
42. Newby LK, Christenson RH, Ohman EM, et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. Circulation 1998;98:1853–1859. 43. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996;93:1651–1657. 44. Ravkilde J, Nissen H, Horder M, et al. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction: analysis of 28 months of follow-up in 196 patients.
Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med 1989;320:618–627. Williams DO, Braunwald E, Knatterud G, et al. One-year results of the Thrombolysis in Myocardial Infarction Investigation (TIMI) phase II trial. Circulation 1992;85:533–542. Terrin ML, Williams DO, Kleiman NS, et al. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial.
Critical Pathways in Cardiology by Christopher P. Cannon (Editor), Patrick T. O'Gara (Editor)